CAC2 Antibody

What is CA II Antibody and what biological molecule does it detect?

CA II Antibody (such as G-2) is a mouse monoclonal IgG2a kappa light chain antibody that specifically detects Carbonic Anhydrase II protein across multiple species. CA II is a cytoplasmic zinc metalloenzyme that catalyzes the reversible hydration of carbon dioxide, critical for acid-base homeostasis. This enzyme is encoded by the human CA2 gene located on chromosome 8q21 and is characterized by its high catalytic activity and extensive tissue distribution. CA II plays essential roles in respiration, bone resorption, and the formation of bodily fluids including saliva and gastric juice .

What laboratory applications is CA II Antibody suitable for?

CA II Antibody (G-2) has been validated for multiple experimental applications:

Each application requires specific optimization and validation procedures to ensure reliable results .

What species reactivity does CA II Antibody demonstrate?

The CA II Antibody (G-2) has demonstrated reactivity against CA II protein from multiple species, including human, mouse, and rat. This cross-species reactivity makes it valuable for comparative studies, but researchers should validate the antibody in their specific experimental system .

How can I validate the specificity of CA II Antibody in my research?

Based on established antibody validation methods, researchers should employ multiple approaches to confirm CA II Antibody specificity:

• Genetic strategies: Use CA II knockout or knockdown cell lines/tissues as negative controls, considered the gold standard for specificity testing .

• Orthogonal strategies: Compare results from antibody-dependent experiments with antibody-independent methods (e.g., mass spectrometry) .

• Independent antibody strategies: Use multiple antibodies targeting different epitopes of CA II and compare binding patterns .

• Recombinant expression strategies: Overexpress CA II in a system with low endogenous expression and confirm increased signal .

• Immunocapture MS strategies: Use mass spectrometry to identify proteins captured by the CA II antibody .

A comprehensive validation would ideally incorporate at least two of these "five pillars" to ensure antibody specificity.

What controls should I include when working with CA II Antibody?

For rigorous experimental design with CA II Antibody, include these controls:

These controls are critical for publication-quality research and addressing the antibody characterization crisis affecting reproducibility in biomedical research .

How should I prepare samples for optimal CA II Antibody detection?

Sample preparation varies by application:

For Western Blotting:

• Use fresh samples or properly stored frozen samples

• Include protease inhibitors in lysis buffers to prevent CA II degradation

• Consider native versus denaturing conditions based on epitope accessibility

• Standard SDS-PAGE followed by transfer to PVDF or nitrocellulose membranes is suitable

For Immunohistochemistry:

• Formalin-fixed paraffin-embedded (FFPE) samples are suitable for CA II detection

• Antigen retrieval methods may be necessary to expose epitopes masked during fixation

• Proper blocking of endogenous peroxidase activity is essential

For Immunofluorescence:

• Fixation with 4% paraformaldehyde is typically effective

• Permeabilization is necessary as CA II is primarily intracellular

• Appropriate blocking agents reduce non-specific binding

What dilution ranges are optimal for different CA II Antibody applications?

Researchers should determine optimal dilutions for each application and lot of antibody through titration experiments. General starting recommendations:

Always validate dilutions empirically for your specific experimental conditions .

How do I interpret Western blot results with CA II Antibody?

When analyzing Western blot data:

• CA II protein has a molecular weight of approximately 29 kDa

• Verify the observed molecular weight against this expected size

• Consider potential post-translational modifications that might cause shifts

• For quantitative analysis, normalize CA II expression to appropriate housekeeping proteins

• Be cautious of cross-reactivity with other carbonic anhydrase isoforms

What are common sources of non-specific binding with CA II Antibody?

Non-specific binding may result from:

• Insufficient blocking

• Too high antibody concentration

• Cross-reactivity with other CA isoforms

• Sample overfixation (for IHC/IF)

• Endogenous peroxidase or biotin activity

To minimize these issues, optimize blocking conditions, perform antibody titration, and include appropriate negative controls in each experiment. Recombinant antibodies generally show improved specificity compared to polyclonal antibodies .

How can I troubleshoot weak or absent CA II Antibody signal?

When experiencing weak signal:

For Western Blotting:

• Increase antibody concentration or incubation time

• Enhance antigen loading

• Optimize transfer conditions

• Use more sensitive detection systems (e.g., chemiluminescent substrates)

• Check sample preparation for potential proteolytic degradation

For Immunohistochemistry/Immunofluorescence:

• Test different antigen retrieval methods

• Increase antibody concentration

• Extend incubation times

• Verify tissue fixation conditions

• Consider signal amplification systems

How can CA II Antibody be applied to study acid-base regulation mechanisms?

CA II Antibody enables sophisticated studies of acid-base homeostasis through:

• Immunolocalization in kidney tissue to map CA II distribution across nephron segments

• Co-immunoprecipitation to identify interactions with acid-base transporters

• Quantitative analysis of CA II expression under acidosis/alkalosis conditions

• Intracellular pH imaging combined with CA II immunofluorescence

These approaches can elucidate CA II's role in renal tubular acidosis, respiratory acid-base disorders, and metabolic conditions .

How can rationally designed antibodies improve CA II targeting specificity?

Recent advances in antibody engineering have enabled rational design of antibodies with improved specificity for target epitopes. For CA II research, this approach could:

• Target specific epitopes unique to CA II that distinguish it from other CA isoforms

• Design complementary determining regions (CDRs) that precisely recognize CA II-specific sequences

• Utilize computational methods to predict optimal antibody-antigen interactions

• Generate synthetic antibodies through grafting of complementary peptides onto stable scaffolds

This rational design methodology has been successfully applied to other proteins and could enhance CA II research specificity .

How does CA II antibody enable studies of protein-protein interactions?

CA II antibody facilitates investigation of protein-protein interactions through:

• Co-immunoprecipitation to isolate CA II and binding partners

• Proximity ligation assays to visualize interactions in situ

• Pull-down assays combined with mass spectrometry

• Immunofluorescence co-localization studies

These techniques have revealed interactions between CA II and sodium bicarbonate cotransporters, important for pH regulation and bicarbonate transport, providing insights into physiological and pathological processes .